| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.081 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |